Chronic kidney disease (CKD) is a condition characterized by a gradual loss of kidney function for a long period of time. It is a worldwide public health problem with an increasing incidence and prevalence. If chronic kidney disease gets worse it may develop complications like high blood pressure, anaemia, lung disease and cardiovascular problems. The objective of this study was to find out mortality rate in nephrology department and to observe the major co-morbid conditions leading to progression of chronic kidney disease and end stage renal disease. A total of 480 patients diagnosed with CKD were enrolled in the study and we observed mortality in 80 patients (16.6 %) and the highest prevalence was observed in age group of 51-60 years. In our study, majority of the mortality cases were observed in patients with diabetes and hypertension. 85 % of patients were on haemodialysis; among them most of the patients were rural residents. This study concludes that CKD is also one of the leading causes of mortality. Central and state authorities must take necessary steps in creating awareness and increase dialysis centres at the rural level, which will significantly reduce the mortality rate and improve quality of life.
Introduction
CKD is defined as the presence of kidney damage, manifested by abnormal albumin excretion or decreased kidney function, quantified by measured or estimated glomerular filtration rate (GFR). 1 CKD is classified by eGFR from stage 1 to stage 5, stage 1 eGFR being more than 90 ml/min and with other renal abnormality such as proteinuria. Stage 2 eGFR is between 60 -90 ml/min, stage 3 (30 -60 ml/min), stage 4 (15 -30 ml/min), and in stage 5 (below 15 ml/min) respectively. 2 Diabetes mellitus, hypertension, www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i8.177 polycystic kidney disease, systemic infections, urinary tract infections, urinary stones, lower urinary tract obstructions and drug toxicity are the causative factors. 3 Uncontrolled diabetes if left untreated causes capillary and tubular basement membrane thickening, glomerular changes include loss of endothelial fenestrations, mesangial matrix expansion, and loss of podocytes with effacement of foot processes. 4 Uncontrolled hypertension leads to high intra-glomerular pressure, impairing glomerular filtration. Damage to the glomeruli lead to an increase in protein filtration, resulting in increased amounts of protein in the urine (microalbuminuria or proteinuria). 5 There are 3 types of renal replacement therapy haemodialysis, peritoneal dialysis, renal transplantation. Haemodialysis is needed when the glomerular filtration rate falls below 15 ml/min/1.73m 2 . 6 In 2015 Global Burden of Disease Study, kidney disease was the 12 th most common cause of mortality, accounting for 1.1 million deaths worldwide. Overall CKD mortality has increased by 31.7 % over the last 10 years, making it one of the fastest rising major causes of death alongside diabetes and dementia. 7 10 % of the population worldwide is affected by CKD and millions die each year because they do not have access to affordable treatment. 8 In another 112 countries, many people cannot afford treatment at all, resulting in the death of over 1 million people annually from untreated kidney failure. 9
Objective
The objective of the study was to find out mortality rate in nephrology department and to observe the influence of major co-morbid conditions leading to progression of chronic kidney disease.
Materials and Methods
This study is conducted in a total of 480 patients for a period of 6 months in a multispecialty hospital. It is a Prospective observational study conducted to find out the mortality rate in nephrology department. Inclusion criteria: Patients age above 10 years. Patients with CKD and co-morbid conditions are included. Exclusion criteria: Out-patients, pregnant women and patients not diagnosed with kidney disease are excluded. Study procedure: Data is obtained through direct communication with patients, care takers and collecting their past medical history, family history, social history, compliance behaviour to haemodialysis.
Results
Of 480 patients with CKD mortality rate was found to be 16.6 %. We observed that the most affected age group was 51-60 years (25 %) followed by 41-50 years (23.75 %) and the mean age was 57.87±15.1 (fig 1) . Highest prevalence of mortality was observed in CKD with diabetes and hypertension (22.5 %) followed by CKD with hypertension (21.25 %). Among them, majority of the patients were above 61 years (42.5 %) as shown in (table 1) . Mortality associated with sepsis was found to be 61.25 % (fig 2) . Of 80 patients, 85 % were on haemodialysis (47.5 % were irregular to dialysis followed by 37.5 % were regular) and 15 % were without dialysis as shown in (fig 3) . The highest prevalence of mortality was observed in 3 to 6 months period (33.75 %), followed by 7 months to 1 year (31.25%) (table  2) . Gender wise distribution: Out of 80 patients, 50 (62.5 %) were male and 30 (37.5 %) were female. Area wise distribution: Of 80 patients, prevalence was higher among rural area 47 (58.75 %) than urban 33 (41.25 %). GFR wise distribution: The mean GFR of 80 mortality patients was found to be 12.06 ± 4.08 ml/min Social history wise distribution: Of 80 mortality, we observed that 27.5 % were alcoholic and 11.25 % were smokers. 0  0  1  3  3  11  18  DM, HTN, PULMO  0  0  1  4  3  5  13  Obstructive nephropathy  0  0  1  1  0  1  3  Hypertension  0  1  2  4  4  6  17  HTN, DM, CARDIO  0  0  0  1  2  5 
Conclusion
Mortality rate was found to be 16.6 % in the present study. Mortality was high in male than female, DM and HTN was the most associated comorbid condition with mortality of CKD patients. Rural residents were found to be more compared to urban; this is may be due to lack of awareness and transportation facilities for haemodialysis. Availability of the clinical pharmacist in the hospital and providing services such as patient education, counseling about the renal disease, identifying the patients at risk of developing CKD, detecting it in early stages, raising the awareness in the general public and health care workers will significantly reduce the prevalence, economic burden on patients, reduce hospital stay, reduce mortality rate and improve the quality of life among CKD patients. Government must take necessary steps in creating awareness and increase dialysis centers at the rural level, which will significantly reduce the mortality rate.
